DNAJC5 and malaria: The prime-boost using the malaria vaccine candidate TRAP (thrombospondin-related adhesion protein), expressed by adenoviral or modified vaccinia virus Ankara viral vectors (viral-vectored TRAP, or vvTRAP), combined with a regime consisting of adenovirus expressing CSP followed by a protein boost (Ad-P) CSP has previously been tested, showing enhancement in protection against a challenge with wild-type P. berghei compared to use of either antigen alone (8).